<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hinnovic &#187; Médicaments</title>
	<atom:link href="http://www.hinnovic.org/category/drugs/langswitch_lang/fr/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.hinnovic.org</link>
	<description>Health Innovations in Context / Les innovations en santé: pour s’y retrouver!</description>
	<lastBuildDate>Tue, 17 Jan 2012 21:21:10 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=abc</generator>
	<language>fr</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>La pharmacogénomique suscite de grands espoirs</title>
		<link>http://www.hinnovic.org/la-pharmacogenomique-suscite-de-grands-espoirs/langswitch_lang/fr</link>
		<comments>http://www.hinnovic.org/la-pharmacogenomique-suscite-de-grands-espoirs/langswitch_lang/fr#comments</comments>
		<pubDate>Tue, 15 Jan 2008 10:00:20 +0000</pubDate>
		<dc:creator>hurfer</dc:creator>
				<category><![CDATA[Médicaments]]></category>
		<category><![CDATA[Pharmaco génomique]]></category>

		<guid isPermaLink="false">http://hinnovic.diagramonline.org/la-pharmacogenomique-suscite-de-grands-espoirs/</guid>
		<description><![CDATA[La pharmacog&#233;nomique, c&#8217;est quoi au juste?

Sur le plan g&#233;n&#233;tique, chaque individu est unique. Le mat&#233;riel g&#233;n&#233;tique dont il est constitu&#233; d&#233;termine la couleur de ses yeux, de ses cheveux, sa morphologie, certaines de ses maladies mais aussi la r&#233;ponse de cet individu face aux traitements m&#233;dicamenteux qui lui sont administr&#233;s.

&#160;
plus&#8230;
]]></description>
			<content:encoded><![CDATA[<p><font color="#4087be"><em><strong><a href="http://www.hinnovic.org/la-pharmacogenomique-suscite-de-grands-espoirs/" title="Les espoirs de la pharmacog&eacute;nomique"><img border="2" align="left" src="http://hinnovic.org/wp-content/uploads/2007/12/pharmacogenomic.jpg" alt="Pharmacog&eacute;nomique" style="padding: 5px; margin-right: 5px;" /></a>La pharmacog&eacute;nomique, c&rsquo;est quoi au juste?</strong></em></font></p>
<div align="justify">
<p>Sur le plan g&eacute;n&eacute;tique, chaque individu est unique. Le mat&eacute;riel g&eacute;n&eacute;tique dont il est constitu&eacute; d&eacute;termine la couleur de ses yeux, de ses cheveux, sa morphologie, certaines de ses maladies mais aussi la r&eacute;ponse de cet individu face aux traitements m&eacute;dicamenteux qui lui sont administr&eacute;s.</p>
</div>
<p>&nbsp;</p>
<p align="right"><span id="more-160"></span><a href="http://www.hinnovic.org/la-pharmacogenomique-suscite-de-grands-espoirs/langswitch_lang/fr" class="more-link">plus&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.hinnovic.org/la-pharmacogenomique-suscite-de-grands-espoirs/feed/langswitch_lang/fr</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What&#8217;s the hype about Pharmacogenomics</title>
		<link>http://www.hinnovic.org/whats-the-hype-about-pharmacogenomics-2/langswitch_lang/fr</link>
		<comments>http://www.hinnovic.org/whats-the-hype-about-pharmacogenomics-2/langswitch_lang/fr#comments</comments>
		<pubDate>Tue, 15 Jan 2008 09:03:15 +0000</pubDate>
		<dc:creator>pboinot</dc:creator>
				<category><![CDATA[Médicaments]]></category>
		<category><![CDATA[Pour regarder]]></category>
		<category><![CDATA[Pharmaco génomique]]></category>

		<guid isPermaLink="false">http://www.hinnovic.org/whats-the-hype-about-pharmacogenomics-2/</guid>
		<description><![CDATA[In this interview, Bryn Williams-Jones comments on the hype surrounding pharmacogenomics: the financial opportunities and risks faced by the industry and governments, the promises to the patients and the issues of accessibility and ethics.
&#160;
&#160;plus&#8230;
]]></description>
			<content:encoded><![CDATA[<p align="justify"><a href="http://www.hinnovic.org/whats-the-hype-about-pharmacogenomics-2/#more-274" title="Interview with Bryn Williams-Jones"><img height="100" align="left" width="150" src="http://www.hinnovic.org/wp-content/uploads/2008/01/bwjones_interview_thumb.jpg" alt="Interview with Bryn Williams-Jones" /></a>In this interview, Bryn Williams-Jones comments on the hype surrounding pharmacogenomics: the financial opportunities and risks faced by the industry and governments, the promises to the patients and the issues of accessibility and ethics.</p>
<p align="right">&nbsp;</p>
<p align="right">&nbsp;<span id="more-274"></span><a href="http://www.hinnovic.org/whats-the-hype-about-pharmacogenomics-2/langswitch_lang/fr" class="more-link">plus&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.hinnovic.org/whats-the-hype-about-pharmacogenomics-2/feed/langswitch_lang/fr</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Economics of Pharmacogenomics</title>
		<link>http://www.hinnovic.org/economics-of-pharmacogenomics/langswitch_lang/fr</link>
		<comments>http://www.hinnovic.org/economics-of-pharmacogenomics/langswitch_lang/fr#comments</comments>
		<pubDate>Tue, 15 Jan 2008 08:00:08 +0000</pubDate>
		<dc:creator>pboinot</dc:creator>
				<category><![CDATA[Médicaments]]></category>
		<category><![CDATA[Évaluation et politiques]]></category>
		<category><![CDATA[Pharmaco génomique]]></category>

		<guid isPermaLink="false">http://www.hinnovic.org/economics-of-pharmacogenomics/</guid>
		<description><![CDATA[
The pharmacogenomics promise essentially suggests that more targeted therapies will be delivered to patients, but rarely discusses if these promises are economically attractive based on the current market dynamics. The pharmacogenomics promises presented in literature suggest these benefits will be achieved either through an improvement in adverse events (by dose adjustments based on genetically determined [...]]]></description>
			<content:encoded><![CDATA[<div align="justify">
<p><a href="http://www.hinnovic.org/economics-of-pharmacogenomics/" title="Economics of Pharmacogenomics"><img align="left" src="http://www.hinnovic.org/wp-content/uploads/2008/01/pills_and_money.jpg" alt="Economics of Pharmacogenomics" /></a>The pharmacogenomics promise essentially suggests that more targeted therapies will be delivered to patients, but rarely discusses if these promises are economically attractive based on the current market dynamics. The pharmacogenomics promises presented in literature suggest these benefits will be achieved either through an improvement in adverse events (by dose adjustments based on genetically determined rates of drug metabolism), or by a more targeted selection of patients (by identifying genetic profiles that show a higher success rate with particular therapies).</p>
</div>
<p>&nbsp;</p>
<p align="right"><span id="more-242"></span><a href="http://www.hinnovic.org/economics-of-pharmacogenomics/langswitch_lang/fr" class="more-link">plus&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.hinnovic.org/economics-of-pharmacogenomics/feed/langswitch_lang/fr</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacogenomics: from promises to public health benefits</title>
		<link>http://www.hinnovic.org/pharmacogenomics-from-promises-to-public-health-benefits/langswitch_lang/fr</link>
		<comments>http://www.hinnovic.org/pharmacogenomics-from-promises-to-public-health-benefits/langswitch_lang/fr#comments</comments>
		<pubDate>Tue, 15 Jan 2008 07:00:01 +0000</pubDate>
		<dc:creator>pboinot</dc:creator>
				<category><![CDATA[Médicaments]]></category>
		<category><![CDATA[Évaluation et politiques]]></category>
		<category><![CDATA[Pharmaco génomique]]></category>

		<guid isPermaLink="false">http://www.hinnovic.org/pharmacogenomics-from-promises-to-public-health-benefits/langswitch_lang/fr</guid>
		<description><![CDATA[Pharmacogenetics &#8211; the relationship between an individual&#8217;s response to particular drugs and their genetic &#8216;make-up&#8217; &#8211; promises to improve health care in a number of ways. However, many questions remain to be answered before the promised benefits are realised in routine clinical practice.
&#160;
plus&#8230;
]]></description>
			<content:encoded><![CDATA[<p align="justify"><a href="http://www.hinnovic.org/pharmacogenomics-from-promises-to-public-health-benefits/" title="Pharmacogenomics: from promises to public health benefits"><img align="left" src="http://www.hinnovic.org/wp-content/uploads/2008/01/man_holding_dna.jpg" alt="Pharmacogenomics: from promises to benefits" /></a>Pharmacogenetics &ndash; the relationship between an individual&rsquo;s response to particular drugs and their genetic &lsquo;make-up&rsquo; &ndash; promises to improve health care in a number of ways. However, many questions remain to be answered before the promised benefits are realised in routine clinical practice.</p>
<p>&nbsp;</p>
<p align="right"><span id="more-223"></span><a href="http://www.hinnovic.org/pharmacogenomics-from-promises-to-public-health-benefits/langswitch_lang/fr" class="more-link">plus&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.hinnovic.org/pharmacogenomics-from-promises-to-public-health-benefits/feed/langswitch_lang/fr</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

